A Phase 1/2 Study of Rigosertib in Patients with Myelodysplastic Syndromes (MDS) and MDS Progressed to Acute Myeloid Leukemia
Source: Leukemia Research - Category: Hematology Authors: Shyamala C. Navada, Steven M. Fruchtman, Rosalie Odchimar-Reissig, Erin P. Demakos, Michael E. Petrone, Patrick S. Zbyszewski, James F. Holland, Lewis R. Silverman Tags: Research paper Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Myelodysplastic Syndrome | Study